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1. THE THESIS EXPLAINED  
 
Nicotinic acid adenine dinucleotide phosphate (NAADP) mediated 
calcium (Ca2+) signalling controls major cellular functions and 
involves an emerging family of intracellular channels specifically 
expressed on acidic compartments: Two-pore channels (TPCs). In 
particular, we have previously demonstrated that TPC2 isoform has 
a key role during angiogenesis and is likely involved in melanoma 
progression. Our earlier results were obtained using a selective 
membrane-permeant noncompetitive antagonist Ned-19 that is able 
to block NAADP- mediated Ca2+ signalling[1, 2]. 
In order to investigate a novel pharmacological tool able to 
interfere with the activity of TPC2 channel we have explored the 
potentiality of a natural flavonoid, Naringenin (Nar), in our 
models. 
In accordance to electrophysiological evidences in a heterologous 
system, i.e. Arabidopsis vacuoles lacking endogenous TPCs, the 
present research has demonstrated that Nar dampens intracellular 
Ca2+ responses of human endothelial cells stimulated with VEGF, 
histamine or NAADP-AM, but not NAADP-independent stimuli,  
ATP and Angiopoietin-1. Moreover, Nar is able to impair 
angiogenesis in vitro and in an in vivo murine model. 
On the basis of these and previous data we have also investigated 
Nar effects on B16 melanoma cells. We have observed that Nar 
impairs NAADP-controlled Ca2+ signalling (stimulated both 
directly and indirectly) and, interestingly, affects cells ability to 
proliferate/and or migrate. Furthermore, B16 melanoma cells 
capability to form vascular-like structures is impaired by Nar. 
Our present data suggest that Nar inhibition of TPC2 activity and 
the observed inhibition of angiogenic response to VEGF are linked 
by impaired intracellular Ca2+ signalling in endothelial cells. In 
addition, Nar effects on B16 melanoma cells strengthen the 
hypothesis that TPC2 represent a potential target for the control of 
the progression of melanoma and possibly of other tumors. The 
relationship we describe in endothelial cells between Nar and 
PhD in Morphogenesis and Tissue Engineering 
 Pag. 7  
TPC2 is therefore likely to have wider implications representing a 
novel tool for experimental, and possibly even clinical, research 
purposes. 
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2.INTRODUCTION 
 
2.2 Calcium signalling complexity in health and diseases 
Calcium (Ca2+) represents the most abundant and ubiquitous 
intracellular second messenger able to mediate different cell 
functions transducing several environmental signals into biological 
responses. Indeed, it’s known that Ca2+ plays an important role in 
some physiological processes such as fertilization, development, 
differentiation, proliferation, contraction, secretion, exocytosis, 
metabolism, gene transcription, apoptosis [3, 4] and angiogenesis 
[1, 5]. Spatiotemporal changes in intracellular Ca2+ concentration 
are coordinated by the intrinsic linking between internal 
compartments and plasma membrane channels. Although the 
maintenance of intracellular Ca2+ homeostasis represents a pivotal 
aspect for cell survival different mechanisms have evolved aimed 
to regulate the Ca2+ removal from the cytoplasm extruding it across 
the cell plasma membrane or sequestering it in intracellular stores. 
Plasma membrane Ca2+ ATPase (PMCA), Na+/ Ca2+ exchanger 
(NCX) and Na+/ Ca2+/ K+ (NCKX) represent the major proteins 
involved in withdrawing Ca2+ from the cytosol into extracellular 
medium. Instead, sarcoplasmic/endoplasmic reticulum Ca2+ 
ATPase (SERCA) pumps and ATPases closely related to SERCA 
contribute to sequestering Ca2+ in the sarco-endoplasmic reticulum 
and nuclear envelope, respectively. Furthermore, also mitochondria 
behave as buffers and stores Ca2+  in particular through the action 
of the inner mitochondrial membrane-spanning mitochondrial Ca2+ 
uniporter (MCU), mitochondrial Na+/ Ca2+ exchanger and the 
permeability transition pore (PTP) [6].  Likewise, Ca2+   influx from 
extracellular space is mediated by channels, pumps and exchangers 
which control Ca2+ entry in response to stimuli such as membrane 
depolarization, stretch, noxious stimuli, extracellular agonists, 
intracellular messengers and depletion of internal compartments 
[4]. For example, the voltage-operated Ca2+ channels (VOCCs) are 
present in excitable cells plasma membrane; consequently to 
membrane depolarization these channels undergo conformational 
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changes that cause Ca2+ influx from the extracellular environment 
down an electrochemical gradient. Finally when intracellular stores 
are empty a process known as store-operated Ca2+ entry (SOCE) 
induces the activation of ORAI1/STIM1 complex that allows Ca2+ 
entry across the plasma membrane [6]. 
Instead, Ca2+ release from intracellular stores is controlled by Ca2+ 
itself or by different Ca2+ mobilizing messengers such as inositol-
1,4,5-trisphosphate (Ins(1,4,5)P3), cyclic ADP ribose (cADPR), 
which mobilize Ca2+ from endoplasmic reticulum stores (ER) and 
nicotinic acid adenine dinucleotide phosphate (NAADP) which 
modulates Ca2+ release from acidic compartments such as 
endosomes and lysosomes [4] (Figure 1).  
 
 
 
 
Parrington J. and Tunn R. Acta Physiol 2014, 211, 285-296 
 
Figure 1. Overview of Ca+2 signalsome: dynamics, homeostasis and release.  
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Global Ca2+ increases that may be transient or sustained, highly 
localized or appear as waves or oscillations represent changes in 
cytosolic free Ca2+ that can be transduced by the cell in a signal 
able to specifically regulate cell processes. Ca2+ signalling 
complexity due to the numerous pathways in which Ca2+ is 
involved implies that Ca2+ signalling deregulation can be a 
characteristic of different pathological states, including cancer [7]. 
Ca2+ signalling alterations are not necessary for cancer initiation 
but represent a pivotal point for tumor progression because Ca2+ is 
involved in relevant biological cancer hallmarks such as the ability 
to avoid apoptosis, self–sufficiency in growth regulation, invasion 
and metastasis, unlimited replication  potential, resistance to anti-
mitotic and anti-angiogenic stimuli, (Figure 2) [8-12]. Ca2+ toolkit 
used by cancer cells is not different from that of non-malignant 
cells but there may be some key alterations. Compared to non-
malignant cells, cancer cells may express Ca2+ channels, pumps, or 
their specific isoforms, not generally present in normal cells of the 
same cell type; they may have important changes in the level of the 
expression, modified cellular localization, post-translational 
modifications, that can induce altered activity, gene mutations or 
changes in activity or expression associated with specific cancer-
relevant processes. Furthermore, these alterations can result in 
changes in Ca2+ flux across intracellular organelles or across the 
plasma membrane [11]. Although Ca2+ signalling represent a new 
recent  field of research  in oncology, understanding how targeting 
Ca2+ channels  pumps or exchangers and the pathways regulated by 
them may represent a novel  area of interest to develop drugs and 
oncological therapy aimed to contrast cancer progression.  
 
PhD in Morphogenesis and Tissue Engineering 
 Pag. 11  
 
 
 
Monteith G. R. et al Nat Rev Cancer 2017, 17, 367-380 
 
 
Figure 2.  A summary of some cancer-associated processes and 
pathways in which Ca2+ is involved. 
 
 
 
2.2 Calcium signalling pathway mediated by NAADP: the 
emerging role of Two-Pore Channels 
NAADP is a potent second messenger able to mobilize Ca2+ from 
compartments different from those activated by IP3 and cADPR. 
Initially discovered in sea urchin eggs [13] it was then confirmed 
in a wide range of cell types [14]. Further characterizations showed 
that NAADP was able to induce Ca2+ release from reserve granules 
(lysosomes-related organelles) and not from the ER suggesting that 
these organelles may operate as Ca2+ stores [15]. Synthesis of 
intracellular NAADP is still a matter of debate to be controversial 
but some ADP-ribosyl cyclases and the mammalin CD38 have 
been shown to catalyze NAADP formation in some cell types; this 
mechanism seems to be the only existing one in biological systems 
[14]. NAADP synthesis can be induced by cellular stimulation or 
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by activation of cell surface receptors to regulate a variety of 
processes such as fertilization, production of nitric oxide (NO) and 
glucose metabolism [14, 16].  
The specificity of Ca2+ release from endolysosomal system 
induced by NAADP is still debated because it has been 
demonstrated that it can also mobilze Ca2+ from sarco-endoplasmic 
reticulum by directly activating RyRs. In particular, in cardiac and 
skeletal muscle, NAADP has been shown to be able to discharge 
Ca2+ through RyR activation [16-18].  In addition, NAADP can 
also elicit Ca2+ release from the same thapsigargin-sensitive pool 
that is sensible to IP3 and cADPR [16, 19-22].  In sea urchin egg 
homogenate IP3, cADPR and NAADP seem to be involved in Ca2+ 
release mechanisms of functionally and pharmacologically distinct 
organelles [23]; in intact cells, instead, an interaction between 
these messengers has been usually observed. Pharmacological 
approaches in sea urchin eggs using IP3R and RyR antagonists 
showed that Ca2+ release induced by NAADP appeared as a 
diffusional gradient [24]. On the basis of these evidences a unified 
hypothesis known as “trigger hypothesis” was proposed. Ca2+ 
acidic stores may trigger a further Ca2+ release from ER by a 
mechanism dependent on functional IP3Rs or RyRs. Local Ca2+ 
released from acidic compartments is amplified in a more 
globalized phenomenon that involves the larger and more 
extensive ER Ca2+ stores, event known as Ca2+-induced Ca2+ 
release (CICR) [14], (Figure 3).  
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Figure 3. The unified “trigger hypothesis”: from a local trigger to a more 
globalized phenomenon.  NAADP induced Ca+2 release from acidic stores that 
causes a Ca+2 release from ER.  
 
 
Different channels such as RyR1 [20], mucolipin 1 (TRPML1) 
[25] and TRPM2 [26], are proposed as molecular targets of 
NAADP Ca2+ fluxes, but the most accredited candidates are a 
family of ion channels named two-pore channels (TPCs)  [27-29]. 
TPCs are members of the voltage-gated cation channels 
superfamily present both in endolysosomes  and vacuoles; they 
represent the only family of Ca2+ release channels present in both 
plant and animal cells, (Figure 4a) [30]. TPCs comprise two 
repeats of a six-trasmembrane pore-forming domain [31] and are 
present in three different isoforms TPC1, TPC2 and TPC3. In 
human and mice there are the first and the second isoforms, while 
in many vertebrates, including chickens and rabbits, there is the 
third isoform [32]. 
TPCs localize to the endolysosomal system but their relative 
density is linked to the phase of maturation of the acidic organelles 
Francesca Papacci 
Pag 14  
and to the different pH.  Indeed, TPC1 is generally expressed in 
recycling endosomes, early and late endosomes and lysosomes 
while TPC2 is predominantly localized into late endosomes and 
lysosomes, (Figure 4b) [33]. 
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Parrington J. et al Int. J. Dev. Biol, 2015, 59:341-355 
b 
 
 
Morgan A. J. et al  Biochem. J., 2011, 439, 349-374 [34] 
 
 
Figure 4. [a] A schematic representation of endolysosomal membrane that 
shows TPCs transmembrane localization. [b] TPCs relative density linked to pH 
and endolysosomal system maturation. 
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Although both TPC1 and TPC2 activation are regulated by 
NAADP, TPC1 seems to be also activated by Ca2+. Moreover, also 
ion conduction and permeability differ considerably. TPCs are 
permeable to a wide range of cations although biophysical data 
propose that TPC2 is slightly more selective for Ca2+ over K+ than 
TPC1 and consequently able of discharging considerable quantities 
of Ca2+ from acidic compartments. It has been shown that TPC1 is 
also permeable to H+ and for this reason it may be involved in the 
regulation of lysosomal and cytosolic pH.  These differences in 
gating and ion conducting properties suggest that TPC1 and TPC2 
may accomplish complementary physiologal roles as Ca2+ release 
channels of endo-lysosomal compartments [35].  
Several studies support the evidence that TPCs mediate Ca2+ 
release evoked by NAADP [28, 35, 36] from acidic stores although 
has been reported evidences indicating that TPCs are not activated 
by NAADP but rather than PI(3,5)P2 [37, 38]. A very recently 
work by Ruas and co-workers shows that NAADP–induced Ca2+ 
release were significantly impaired in cells TPC1 and TPC2 double 
knock out corroborating the hypothesis that both TPC1 and TPC2 
are NAADP targets [39]. Finally, the possible explication of such 
contrasting data is that NAADP may not directly interact with 
TPCs, but through an accessory binding protein [40, 41] element 
that might be lost in the different experimental conditions [42]. 
 
 
 
2.3 Role of NAADP and TPCs in pathophysiological processes 
Ca2+ signalling from TPCs evoked by NAADP is involved in 
different physiological processes including cellular differentiation, 
muscle contraction, endothelial activation, membrane trafficking, 
autophagy, nutrient sensing exocytosis, fertilization and 
embryogenesis, cytokinesis [42] and pigmentation [43-45]. 
Furthermore, in our laboratory we have recently demonstrated the 
emerging role of NAADP elicited pathway, in particular mediated 
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by TPC2, in angiogenesis. Indeed, in angiogenic process Vascular 
Endothelial Growth Factor (VEGF) signalling pathway play a 
pivotal role. Activation of Vascular Endothelial Growth Factor 
receptor 2 (VEGFR2) results in an increase in intracellular free 
Ca2+ mediated by NAADP that controls proliferation, migration 
and sprouting of endothelial cells (ECs). In vitro experiments in 
human umbilical vein endothelial cells (HUVECs), using a 
selective NAADP antagonist (Ned-19) or anti-TPC2 shRNA, 
showed a drastic inhibition of angiogenesis due to the significant 
reduction of VEGF-induced intracellular Ca2+ mobilization. 
Moreover, in in vivo experiments Ned-19 inhibited VEGF-induced 
vessels formation in matrigel plugs and accordingly in TPC2 
knockout mice, but not TPC1 knockout mice, VEGF-induced 
vessels formation in matrigel plugs failed to occur [1]. 
Interestingly, recent studies reported the emerging role of TPCs in 
several pathologies such as myocardial ischemia [46], Parkinson’s 
disease [47] and Ebola virus infection [48].  
Recently TPCs mediated Ca2+ signalling has been described also in 
cancer. Indeed, a genetic analysis aimed to indentify genetic 
factors implicated in development and metastasis of human oral 
squamous carcinoma showed an over-expression of TPC2 gene as 
a possible driver of the amplification of 11q13 genomic region 
detected in distinct tumors but the mechanism that links TPC2 
overexpression to changes in growth and metastatic potential still 
remains unclear. 
Moreover, studies about the relationship between genes involved in 
skin pigmentation and the tendency for malignant melanoma have 
shown the possible correlation between cancer and TPC2. TPC2 
gene polymorphisms has been identified as potential risk factors in 
this pathology. Furthermore, melanosomes are modified lysosomes 
and changes in TPC2 expression or function induces abnormalities 
on melanocytes biology that could enhance tumorigenity [49]. 
Involvement of NAADP-mediated responses in melanoma 
progression have been demonstrated also in my laboratory. Indeed, 
in in vitro experiments we have shown that VEGF-dependent Ca2+ 
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signalling is significantly reduced in B16 murine melanoma cells 
treated with NAADP-inhibitor Ned-19 and also in in vivo 
experiments in mice we have demonstrated a significant reduction 
of tumor growth and metastasis formation after four weeks of 
intraperitoneal Ned- 19 treatment [2]. In addition, data from 
Nguyen and co-workers indicate TPCs as possible targets of 
invasive cancers. In a very recent article they have shown that 
TPCs inhibition impairs migration and adhesion of T24 (bladder 
cancer), HUH7(hepatocarcinoma) and 4T1 (breast cancer) cancer 
cells in vitro and metastasis formation in a in vivo mouse model as 
result of altered integrin trafficking in the endolysosomal 
compartment [50]. 
The biological relevance of TPCs-mediated signalling in diseases, 
and in particular in cancer, make them possible targets for drugs 
development aimed to fight cancer development and progression. 
 
 
 
2.4 Biological properties of flavonoids: focus on Naringenin 
Flavonoids have aroused researchers interest for their indisputable 
biological properties supported by epidemiological studies that 
propose a direct link between the consumption of food rich in 
flavonoids and poor in fatty acids and a decreased risk of certain 
diseases in humans such as cardiovascular diseases, diabetes and 
cancer. Due to their antioxidants properties flavonoids seem to 
have also a pivotal role in the aging process, tissue damage and 
inflammatory processes [51]. Moreover, they exert a potential anti-
invasive and/or anti-metastatic activities in a wide range  of cancer 
types such as brain, thyroid, lung, prostate, ovarian, cervical, oral, 
hypopharyngeal, breast, liver, biliary tract, gastric, pancreatic, 
intestinal colon, renal and epidermal cancers, melanoma, 
fibrosarcoma, osteosarcoma and Kaposi’s sarcoma, (Figure 5) [52]. 
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Figure 5.  Overview of flavonoids with anti-invasive and/or anti-metastatic 
properties in the fight of a variety of cancer types. 
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Naringenin (Nar) (5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-
one) is one of the main flavonoids present in human diet, (Figure 
6). 
 
 
 
Figure 6.  Chemical structure of Naringenin. 
 
 
Evidences from epidemiological reports showed that the 
consumption of vegetables and fruit with a high Nar content, such 
as citruses and tomatoes or their food products, correlate with a 
reduced incidence of metabolic and chronic-degenerative diseases 
[53, 54]. Several in vitro studies have shown that Nar interacts with 
many cellular pathways, point out its properties as an antioxidant, 
antinflammatory, chemopreventive an antidegenerative agent [55]. 
In addition, it has been shown that Nar is able to exert anti-
angiogenic effects in vitro impairing endothelial cell proliferation, 
survival, migration and capillary-like structures formation of 
HUVECs and in vivo reducing neovascularization in an avian 
chorio-allantoid membrane model [56]. Furthermore, in rats 
nourished with high-cholesterol diet Nar is able to lower plasma 
and hepatic cholesterol concentrations by suppressing HMG-CoA 
reductase and ACAT [57]. The potential of Nar and its precursor 
naringin emerged from pre-clinical studies which described their 
activity in treatment of metabolic and cardiovascular disorders 
such as hyperlipidemia, hypertension, cardiac toxicity, 
hyperglycemia and diabetes, hepatic steatosis, atherosclerosis [54] 
and cancer [55]. Indeed, Nar chemopreventive and anticancer 
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activity has been described; it has been shown that Nar is able to 
block the progression and the formation of metastasis in different 
experimental models of oral [58], melanoma [59], breast [60, 61], 
colon[62], lung [63], and liver [64] cancers. It seems to act by 
upregulating many different cell survival proteins or arresting cell 
cycle, by inducing p53-dependent apoptosis or inhibiting 
inflammatory processes and, in some cases, by exploiting all of 
these mechanisms [52, 65, 66]. Interestingly, it is known that Nar 
affects also the activity of different calcium-activated or calcium-
permeable ion channels. Nar 100 µM  induces a threefold increase 
in the currents mediated by large conductance Ca2+-activated K+ 
(BKCa) channels, which can be closely correlated with the 
significant vasorelaxant effect mediated by Nar on rat 
endothelium-denuded vessels [67]. Moreover, the relaxant effect of 
Nar on rat colon smooth muscle has been attributed to the direct 
activation of BKCa channels, resulting in hyperpolarization of 
smooth muscle cells, which in turn reduces the Ca2+ influx through 
voltage-dependent calcium channels [68]. Furthermore, Nar is a 
powerful inhibitor of the melastatin-related transient receptor 
potential TRPM3 belonging to the TRP family, a calcium-
permeable non-selective cation channel expressed in various neural 
and non-neural tissues, activated by neurosteroids and heat [69]. 
Since TRPM3-deficient mice display an impaired perception of 
noxious heat, the inhibition of TRPM3 may represent a novel tool 
for analgesic therapy [70]. Another member of the TRP family, 
TRPP2 or polycystin-2, a Ca2+-permeable non-selective cation 
channel located in the ER and in the primary cilium, is modulated 
by Nar concentrations ranging from 50 to 200 µM. This channel is 
implicated in the development of autosomal dominant polycystic 
kidney disease (ADPKD). It has been suggested that Nar may 
activate TRPP2 to cause Ca2+ influx and a decrease in cellular 
proliferation, thereby providing a novel therapeutic approach to 
ADPKD [71]. Despite the fullness of evidence on Nar efficacy, an 
exhaustive explanation of its mechanism of action is still lacking, 
Francesca Papacci 
Pag 22  
as is the experimental evidence needed to bridge the gap between 
multiple cellular targets and biological response. 
 
 
 
2.5 Physiological angiogenesis versus tumoral angiogenesis: a 
general overview 
Angiogenesis is the physiological process that foresees the 
formation of the new blood vessels from pre-existing ones. 
Although angiogenesis is a phenomenon which occurs throughout 
life, in the adult the vasculature is generally quiescent and 
physiological angiogenesis is restricted to some adult tissues that 
require regeneration or restructuring (including female 
reproductive organs or injured tissue) [72, 73]. 
Angiogenesis is characterized by two different mechanisms: 
sprouting and splitting (or intussusceptive angiogenesis).  
In sprouting angiogenesis enzymatic mechanisms induce 
degradation of capillary basement membrane, ECs proliferate and 
migrate, there is a tube formation, vessel fusion and pruning and 
the stabilization of pericytes. This process begins when tissues are 
poorly perfused and critical hypoxic levels require blood vessels 
formation aimed to meet the metabolic needs of parenchymal cells. 
As a response to the hypoxic conditions several parenchymal cells 
produce VEGF, a key factor that plays a pivotal role during early 
stages of angiogenesis. The sprouting process is guided by a tip 
cell which displays filopodia that moves toward VEGF gradient 
concentration through VEGF-VEGFR2 interaction. Tip cell 
determination is controlled by the cell-cell signalling pathway 
Delta-Notch that is activated by interaction of VEGF with ECs.  
Capillary sprout elongation is determined by contraction of 
filaments within the filopodia that draw the tip cell along toward 
the VEGF source causing consequent proliferation of endothelial 
stalk cells [72]. 
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Life Sciences; 2010. Chapter 1. 
 
 
Figure 7. Different steps which characterize sprouting angiogenesis. 
 
 
Convergence of tip cells from different capillary sprouts toward 
VEGF stimulus source induces the fusion of these cells causing the 
formation of a continuous lumen perfusible by oxygenated blood. 
Finally, consequent involvement of pericytes and the extracellular 
matrix deposition, including the arrest of ECs proliferation, 
contributes to the capillary maturation and stabilization [72] 
(Figure 7).  
Pro-angiogenic factors (for example VEGF, angiopoietins, 
epidermal growth factor (EGF), transforming growth factor-α 
(TGF-α), fibroblast growth factor (FGF)) and anti-angiogenic 
factors (for example angiostatin, endostatin, thrombospondin) 
contribute to the correct functioning of the angiogenic process 
[74]. 
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Splitting angiogenesis or intussusceptive angiogenesis, instead, is a 
phenomenon that plays a key role in the growth and remodelling of 
most vascular beds, including those of the tumor. During this 
process a single vessel splits in two different vessels. Invagination 
of the capillary walls into the vascular lumen induces the formation 
of intraluminal tissue pillars. The vessel wall of the opposite sides 
of a vessel extend toward each other forming an intraluminal pillar. 
In the following phases of the splitting, reorganization of the 
interendothelial junctions and the formation of the core of the pillar 
occur and afterwards pericytes and myofibroblsts invade the pillar. 
Finally fusion of different pillars induces the splitting of the initial 
capillary in two different ones, (Figure 8) [75]. 
 
 
 
Adair T.H., Montani J.P.  Angiogenesis. San Rafael (CA): Morgan & Claypool 
Life Sciences; 2010. Chapter 1. 
 
Figure 8.  Representation in three dimensions (a-d) and two dimentions (a’-d’) 
of different steps of intussusceotive angiogenesis. Endothelial cells (EC); 
basement membrane (BM); fibroblasts (Fb); pericytes (Pr); collagen fibrils (Co). 
 
 
Moreover, intussusceptive angiogenesis has been recognized in 
three different forms: intussusceptive microvascular growth, 
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intussusceptive arborisation and intussusceptive branching 
remodelling [75, 76]. 
Intussusceptive angiogenesis seems to be a fast and efficient 
process that occurs in pre-existing vascular systems previously 
formed by vasculogenesis or sprouting angiogenesis without 
interfering with the local physiological conditions. Indeed, this 
type of angiogenesis occurs throughout life but plays a pivotal role 
during embryonic vascular formation in a context in which growth 
is fast and resources are limited [72]. Furthermore, splitting 
angiogenesis seems to be regulated both by hemodynamic forces 
and pro- angiogenic factors such as VEGF, angiopoietins, FGF and 
PDGFβ [75]. 
In general, loss of the appropriate balance between pro- and anti- 
angiogenic factors induces abnormalities in physiological 
angiogenic process toward a pathological angiogenesis, 
phenomenon known as “angiogenic switch” [73]. In cancer, for 
example, angiogenesis has a key role. Indeed tumor vessels supply 
tumor with oxygen, nutrients and subsequently remove waste. 
When tumors arise in a well vascularized region co-option of pre-
existing vessels might be exploited. On the contrary, angiogenesis 
or the formation of new blood vessels from a pre-existing system 
occurs to guarantee tumor expansion. In this context the creation of 
a pro-angiogenic environment promotes the induction of growth 
vascular. Tumor secrete growth factors that produce a 
chemotactive gradient able to recruit ECs and perycites while 
matrix metalloproteinases generate remodelling of extracellular 
matrix aimed to facilitate migration and vascular morphogenesis 
[77]. 
Tumor blood vessels are architecturally different to the normal 
counterpart and show some characteristic hallmarks. There is not a 
specific organization in venules, arterioles and capillaries but blood 
vessels are usually chaotic, irregular, dilated, tortuous and can have 
dead end. The vascular system is leaky and haemorrhagic and in 
addition tumor vessels may have cancer cells integrated in the 
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vessel wall. Moreover, blood perfusion may be irregular and slow, 
(Figure 9) [73]. 
 
  a                                                  b 
 
 
Modified from McDonald D.M. and Choyke P.L.  Nat Med 2003, 9(6):713-25 
 
Figure 9. Representative microscopic imaging of normal [a] and tumor 
vasculature [b]. [a] In normal blood vessels it is possible to observe a precise 
vascular network organization in arterioles, capillaries and venules. [b] Tumor 
blood vessels appear chaotic and not hierarchically organized [78]. 
 
Recently, several evidences show alternative mechanisms through 
which vascular supply can be formed in solid tumors, as 
represented in Figure 10. Co-option process foresees that tumors 
adopt pre-existing blood vasculature of the surrounding 
environment. In vascular mimicry, instead, aggressive tumor cells 
themselves, rather than endothelial cells, form capillary-like 
structures perfusible by blood able to provide support to cancer 
growth [79].  Initially discovered in melanoma, additional studies 
have demonstrated that several aggressive cancers such as some 
sarcomas, carcinomas or gliomas can display vascular mimicry 
[80, 81]. 
 
 
PhD in Morphogenesis and Tissue Engineering 
 Pag. 27  
 
Cao Y. Chin J Cancer, 2016, 35:21 
 
Figure 10.  Different mechanisms exploited by solid tumors in order to provide 
blood supply supporting tumor growth, metastasis and drug resistance. 
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3. AIMS 
 
In our previous studies we have demonstrated the emerging role of 
Two-Pore Channel 2 in angiogenesis and its likely involvement in 
melanoma progression. Indeed, we have described that HUVECs 
treated with the NAADP inhibitor Ned-19 or anti-TPC2 shRNA 
showed a drastic inhibition of angiogenesis due to the significant 
reduction of VEGF-induced intracellular Ca2+ mobilization. 
Moreover, in in vivo experiments Ned-19 inhibits VEGF-induced 
vessels formation in matrigel plugs and in TPC2 knockout mice, 
but not TPC1 knockout mice, VEGF-induced vessels formation in 
matrigel plugs failed to occur [1]. Furthermore, we have also 
demonstrated that Ned-19 is able to block growth, migration, 
adhesivity and VEGFR2 expression in B16 melanoma cells in vitro 
and tumor growth, metastasis formation and vascularization in 
vivo. Collectively, these observations propose NAADP/TPC2 
signalling pathway as a key point not only for neoangiogenesis but 
also for the direct contol of tumor cells [2].  
On this basis our laboratory is presently engaged in a number of 
experimental approaches with the ultimate aim of assessing 
whether TPC2 can be a suitable target for potential melanoma 
therapy. My specific contribution to this aim has been characterize 
a novel pharmacological tool exploring the potentiality of a natural 
flavonoid, Naringenin, in our models. 
To this purpose we have focused our attention on Nar ability to 
modulate TPCs activity, given that Nar interferes different Ca2+ 
channels [67-71], in order to investigate its effects on VEGF-
dependent angiogenesis and in melanoma behavior. 
In particular the aims of this work are: 
- In HUVECs : to evaluate Nar effects on NAADP-controlled  Ca2+ 
responses through calcium imaging experiments and investigate 
Nar effects on VEGF-dependent angiogenesis in vitro and in vivo. 
- In B16 melanoma cells: to evaluate Nar effects on NAADP-
controlled  Ca2+ responses through calcium imaging experiments 
and to investigate Nar effects on biological cancer processes such 
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as migration, proliferation and non-angiogenic vasculogenic 
mimicry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Francesca Papacci 
Pag 30  
4. RESULTS AND DISCUSSION 
 
4.1 Naringenin affects the activity of the human TPCs directly 
impairing hTPC2 functional activity and decreasing hTPC1 
activity  
 
Mature plant cells have a particular intracellular compartment that 
is lacking in animal cells: the vacuole. Its large dimension and its 
easy isolation allow researchers to study it using patch-clamp 
techinique. Through this method it is possible to isolate a specific 
small patch of a membrane and precisely detect the current flowing 
through a single ion channel. Interestingly, in this way is possible 
to exploit A. Thaliana vacuole as a novel heterologous system for 
the expression and functional characterization of animal 
intracellular channels and transporters [82]. 
In collaboration with Armando Carpaneto group from CNR of 
Genoa, we have employed this heterologus system to assess the 
ability of Nar to bind and regulate the activity of human TPC2 
(hTPC2). Isolated protoplasts of a mutant A. thaliana, lacking 
endogenous TPCs, were transiently transformed with hTPC2 
equipped with an EGFP fused to its C-terminus [83]; we applied 
the patch-clamp technique to vacuoles in which GFP fluorescence 
was clearly detectable on the tonoplast. The addition of 330 nM 
PI(3,5)P2 in the external (cytosolic) solution induced robust 
hTPC2-mediated currents, as shown in Figure 1a where stationary 
currents recorded at +40 mV were plotted versus time. When 500 
µM Nar was also added in the cytosolic solution a strong decrease 
in the activity of hTPC2 currents was evident. Figure 1b shows 
control and recovery currents (∆I) recorded in the presence of 
PI(3,5)P2 subtracted by the correspondent background recorded 
without the phosphoinositide. Upon Nar application, currents were 
drastically reduced at both +40 and −40 mV voltages. Even if 
recorded in symmetrical concentration of sodium, due to a voltage-
dependent block by cytosolic magnesium [84] the currents at +40 
mV were smaller than those recorded at −40 mV. Interestingly, 
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Nar inhibition was fully reversible (Figure 1b). The dose-response 
was well described by a Michaelis-Menten hyperbolic function 
(Figure 1c), with apparent affinity constants of 180 ± 20 µM at +40 
mV and of 240 ± 40 µM at −40 mV, therefore not significantly 
different. 
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Figure 1. Naringenin inhibits the activity of the human TPC2 channel. (a) Time 
course of current amplitude recorded in response to bath application of 330 nM 
PI(3,5)P2 (upper black bar) before and after adding 500 µM Nar (upper blue 
bar). Each point represents the steady-state current at +40 mV. (b) Currents 
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mediated by hTPC2 and induced by the application of 330 nM PI(3,5)P2 in the 
cytosolic bath solution were recorded at +40 and −40 mV (shown in the upper 
voltage profile) in the absence or presence of 500 µM cytosolic Nar. For the 
sake of clarity, background currents in the absence of the phosphoinositide were 
directly subtracted. (c) Dose–response analysis of Nar inhibition. Inorm, the 
normalised current, was obtained by the ratio of currents recorded respectively 
in the presence and absence of cytosolic Nar. Both at +40 and −40 mV, 
normalised currents at different Nar concentrations were fitted with a Michaelis–
Menten function (continuous lines). Data from 3 (Nar33 µM), 6 (Nar 100 µM) 
and 9 (Nar 500 µM) different vacuoles were shown as mean  ±  s.e.m. Values 
at positive and negative voltages, at a defined Nar concentration, were not 
significant (P > 0.2); values at different Nar concentrations and at a defined 
voltage (+40 or −40 mV), were statistically significant (at least P < 0.01). 
 
 
We wondered if Nar could modulate the other member of the TPC 
family in humans, namely hTPC1. We therefore performed a 
similar approach as for hTPC2 and expressed hTPC1 fused to an 
EGFP at its C-terminus in Arabidopsis Thaliana vacuoles lacking 
the endogenous TPC1. Suppl. Figure 1a, left panel, shows that the 
background currents recorded in the absence of PI(3,5)P2 are very 
small in comparison to those elicited by the addition of the 
phosphoinositide (right panel). We chose a concentration of 
PI(3,5)P2 equal to 90 nM and therefore near to the saturation value 
since the apparent binding constant in this experimental condition 
was about 20 nM [85]; in comparison the affinity binding constant 
of PI(3,5)P2 for hTPC2 is about 140 nM [83]. The current-voltage 
relationship in the absence (empty symbols) and in the presence 
(filled symbols) of PI(3,5)P2 was plotted in Suppl. Figure 1b. In a 
recent paper [85] we demonstrated that the functionality of hTPC1 
was strongly affected by both cytosolic and luminal Ca2+, namely 
an increase in cytosolic and luminal Ca2+ induced an increase and a 
decrease of the activity of the channel, respectively. 
Here, our standard pipette and ionic bath solutions (see Materials 
and Methods) allowed us to record hTPC1-mediated currents at 
both negative and positive potentials and therefore to evaluate the 
effect of Nar at different voltages. In Suppl. Figure 1b, at positive 
voltages, a voltage dependent inhibition of the hTPC1-induced 
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currents due to the presence of cytosolic magnesium was also 
apparent [85]; a similar effect was recorded for hTPC2 in Figure 
1b and by other authors [84]. Figure 2a showed that the addition to 
the cytosolic solution of 500 µM Nar (trace 2) induced a significant 
decrease of hTPC1-elicited currents (trace 1) at both negative and 
positive voltages and had almost no effect in control conditions 
(compare trace 3 and 4). The inhibition of hTPC1 by Nar was 
quantified in the histogram of Figure 2b; the effect was not 
voltage-dependent. Moreover, we verified that Nar decreased the 
activity of the endogenous Arabidopsis TPC1 (Suppl. Figure 2) 
showing that the inhibition of TPC channels by Nar was a 
mechanism conserved during evolution. 
 
All supplementary figures are showed in the appendix of the thesis. 
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Figure 2. The activity of the human TPC1 channel is inhibited by Naringenin. 
(a) Currents (lower panel) recorded in control conditions (trace 4) or adding in 
the cytosolic bath solution: 90 nM PI(3,5)P2 (trace 1), 90 nM PI(3,5)P2 and 500 
µM Nar (trace 2), 500 µM Nar (trace 3). In the upper panel the voltage profile is 
shown. (b) Percentage of current inhibition induced by 500 µM Nar added in the 
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cytosolic solution at −40 and + 40 mV. Data from 6 different vacuoles, shown as 
mean ±s.e.m., were not statistically significant (P > 0.6). 
 
 
4.2 Naringenin significantly inhibits VEGF-dependent calcium 
mobilization in a dose-dependent manner 
 
In HUVECs, we have previously demonstrated that VEGF- 
dependent Ca2+ mobilization evoked by NAADP is impaired 
pretreating cells with Ned-19 (a noncompetitive antagonist of 
NAADP) [1].  In order to evaluate the possible inhibitory effect of 
Nar on the regulation of VEGF-dependent Ca2+ signalling in 
human cells, calcium imaging experiments were performed 
pretreating HUVECs for 30 min with different concentrations of 
Nar and stimulating them with 100 ng/ml VEGF. Figure 3a,b 
shows that  Ca2+ mobilization was significantly reduced in a dose-
dependent manner without affecting VEGFR2 phosphorylation at 
Tyr1175 demonstrating that the inhibition of the responses occurs 
downstream of the receptor , (Figure 4).  Furthermore, opting for 
1000 µM Nar, for its highest effect, we have analyzed the 
specificity of this response for NAADP/TPC2- dependent Ca2+ 
signalling using a positive and a negative control. Bar charts in 
Figure 3c,d show that Nar fails to block Ca2+response to ATP, 
known to be IP3-dependent, but blocks histamine-evoked Ca2+ 
release known to be NAADP/TPC2-dependent [86]. These data are 
a strong indication that Nar is able to reduce Ca2+ release inhibiting 
hTPC2.  Finally, to better correlate the specific inhibitory effect of 
Nar treatment on TPC2, calcium imaging experiments with the 
direct channel activator were performed. HUVECs Ca2+ 
mobilization in response to 500 nM NAADP-AM was significantly 
impaired pretreating cells with 500 µM or 1000 µM Nar. These set 
of experiments were accomplished in a Ca2+ free buffer to tightly 
evaluate the intracellular Ca2+ involvement alone thus limiting 
possible off-target responses (Figure 3e). 
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Taken as a whole, these data strongly suggest a direct effect of Nar 
on TPC2 given that it affects specifically Ca2+ released from acidic 
intracellular compartments. 
 
 
Figure 3.  VEGF and NAADP-AM-dependent Ca2+ mobilization from acidic 
stores  is  inhibited by Naringenin . Live imaging in single FURA-2AM loaded 
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cells. (a,b) HUVECs were pretreated for 30 min with different concentrations of 
Nar and then stimulated with 100 ng/ml VEGF; (a) Bar chart showing maximum 
Ca2+ concentrations; (b) Changes in Ca2+ levels shown as representative traces. 
(c,d) Cells were pretreated with 1000 µM Nar for 30 min and then stimulated 
with (c) 10 µM ATP (negative control) or (d) 100 µM histamine (positive 
control). (e) Cells were pretreated with 500 µM or 1000 µM Nar and then 
stimulated with 500 nM NAADP-AM. Data in bar charts were from 3 
independent experiments, n = 41–180 cells. *P < 0.05; **P < 0.01; ***P < 
0.001.  
 
 
 
 
Figure 4. Phosphorylation state of VEGFR2 at Tyr1175, evaluated by western 
blot in untreated (NT) or VEGF-treated HUVECs. (a) Cells were preincubated 
with Nar (200 µM, 600 µM and 1000 µM) or vehicle for 30 min, or with TSU-
68 (2,1 µM), or its control (vehicle-2) for 1h. Samples were then stimulated with 
100 ng/ml VEGF for 15 min. The intensity of pVEGFR2 bands was quantified 
and normalized to α-tubulin content. (b) Data in bar chart represent mean ± 
s.e.m. from three independent experiments. As apparent, VEGF-induced 
receptor phosphorylation is significantly inhibited by TSU-68 but not by Nar. 
 
 
 
4.3 Naringenin impairs VEGF-induced angiogenic process in 
vitro and in vivo 
 
Li et al recently have demonstrated the antiangiogenic effects of 
Nar on HUVECs in vitro and in the avian chorio-allantoid 
membrane model in vivo. Although its antiangiogenic effects have 
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been reported to involve impairment of estrogen-related receptor α 
(ERR α) and VEGF secretion, the specific pathway involved has 
yet to be understood [56].  Previously, we have demonstrated that 
NAADP-mediated Ca2+ signalling has a key role in the regulation 
of in vitro and in vivo angiogenesis. VEGF-induced angiogenesis 
was inhibited by Ned-19 in vitro and in an established in vivo 
murine model [1]. In order to explore the anti-angiogenic effects of 
Nar we have evaluated VEGF-dependent angiogenesis in vitro and 
in vivo. 
HUVECs have the ability to form capillary-like tubes in vitro, 
characteristic that is commonly considered as representative of 
later, differentiative, steps of angiogenesis. In this way exploiting 
this assay it is possible to analyze the pro or anti-angiogenic effects 
of a compound. ECs plated onto matrigel matrix adhere, migrate 
and, within a few hours, differentiate into capillary- like structures. 
Figure 5 shows that both 1000 µM  or 500 µM Nar significantly 
impaired the number of closed polygons formed by cells stimulated 
with VEGF compared with samples stimulated with VEGF alone. 
This evidence points out that Nar regulates VEGF-induced 
capillary-like formation in vitro specifically inhibiting the 
NAADP/TPC2- mediated Ca2+ signalling. 
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Figure 5.  HUVECs ability to form capillary-like structures induced by VEGF 
in vitro were impaired by Naringenin. (a,c) Representative images of one of 
three independent experiments. HUVECs were plated in Matrigel-coated dishes 
and incubated for 3–4 h in EBM-2 + 2% FBS supplemented or not with VEGF 
or Nar 1000 µM (a) and 500 µM (c) or in medium containing both VEGF and 
Nar. (b,d) Quantitative evaluation of tube formation as the number of closed 
polygons formed in 6 fields for each experimental condition. Data in bar charts 
represent mean ± s.e.m. of three independent experiments. *P < 0.05 
 
 
In our in vivo murine model we have previously demonstrated that 
VEGF-treated plugs implanted in the flank of wild type mice not 
only failed to be vascularized if treated with Ned-19, but more 
strikingly remained avascular in TPC2 - /- mice. In addition, the 
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specific role of TPC2 was supported by the evidence that 
vascularization was not inhibited in plugs from TPC1 -/- mice [1]. 
To verify the inhibitory effect of Nar on in vivo angiogenesis 
C57BL/6 were injected with matrigel plugs containing either Nar 
or vehicle, or Nar plus VEGF; five day later the extent of plug 
vascularization under the different experimental conditions was 
evaluated by measuring the hemoglobin content. Figure 6 shows 
that while VEGF alone induces significant vascularization, plugs 
treated with VEGF plus Nar remain virtually avascular.  
Interestingly, our observations in vivo open a new perspective 
toward a potential therapeutic approach although we cannot 
exclude the possibility that targets other than TPC2 may contribute 
to this antiangiogenic effect. 
 
 
 
 
 
 
Figure 6. Naringenin affects vascularization induced by VEGF in a in vivo 
murine model. Male/female C57BL/6 mice 5 weeks old were injected 
subcutaneously with matrigel plugs containing either vehicle or VEGF or VEGF 
plus 1000 µM Nar. Five days after injection the mice were sacrificed and plug 
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vascularization was evaluated both macroscopically, as shown in two 
representative images (a) and  as hemoglobin content expressed as absorbance 
(OD)/1 g matrigel plug (b);  values from three independent experiments are 
expressed as mean ± s.e.m. *P < 0.05. n = 14–15 plugs for each experimental 
condition. 
 
 
4.4 Naringenin does not impair NAADP/TPC2-independent 
angiogenic responses  
 
We have previously shown and analyzed that intracellular 
Ca2+signalling is involved in HUVECs angiogenic responses to 
Angiopoietins. Evidence from pharmacological inhibition of 
different Ca2+ release channels showed that neither the increase of 
intracellular Ca2+ nor the angiogenic responses elicited by 
Angiopoietin-1 (Ang-1) are dependent on NAADP-TPC2 pathway. 
In fact, both response were significantly impaired by thapsigargin, 
which inhibits SERCA pumps, but not by bafilomycin A1, which 
inhibits pH-dependent Ca2+ uptake into acidic stores [5].  
To further validate the hypothesis that Nar specifically impairs 
angiogenic responses inhibiting NAADP/TPC2 signalling pathway 
we tested Nar effect on HUVECs stimulated with Ang-1, as an 
angiogenic stimulus that does not couple with TPC2, using Ned-19 
as positive control. To this aim calcium imaging experiments were 
performed. Cells were pretreated for 30 min with Nar (Figure 7a) 
or Ned-19 (Figure 7b) and stimulated with 100 ng/ml Ang-1. Both 
Nar and Ned-19 failed to impairs Ang-1-dependent Ca2+ 
mobilization corroborating our aforementioned hypothesis.  
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Figure 7. Neither Naringenin nor Ned-19 impairs Ang1-dependent Ca2+ release. 
Live imaging in single FURA2-AM loaded cells. (a) HUVECs were pretreated 
for 30 min with 500 µM or 1000 µM Nar and then stimulated with 100 ng/ml 
Ang-1. Both Nar concentrations failed significantly inhibit Ang-1 mediated Ca2+ 
release (P >0,2). (b) Calcium imaging experiments in HUVECs pretreated for 30 
min with 100 µM Ned-19 and then stimulated with 100 ng/ml Ang-1. Bar chart 
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shows that Ang-1induced-increase in [Ca2+]i is not impaired by Ned-19.  Data 
were from 3 independent experiments ***P<0,001. 
 
 
Likewise we have analyzed whether Nar was able to impair 
NAADP/TPC2-independent angiogenic responses in vitro and in 
vivo. As expected, Ang-1 stimulated HUVECs capability to form 
capillary-like structures on matrigel, but both Nar (Figure 8a,b) and 
Ned-19 (Figure 8c) failed to interfere with this phenomenon in 
vitro. 
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Figure 8. Naringenin does not affect angiogenic responses to Ang-1 in vitro. (a) 
Representative images of one of three independent experiments. HUVECs were 
plated in Matrigel-coated dishes and incubated for 2–3 h in EGM-2 
supplemented or not with Ang-1 or Nar, or in medium containing both Ang-1 
and Nar. (b) Quantitative evaluation of tube formation as the number of closed 
polygons formed in 6 fields for each experimental condition. Data in bar charts 
represent mean ± s.e.m. of three independent experiments. *P < 0.05.  (c) Cells 
were plated in Matrigel-coated dishes and incubated for 2-3 h in EGM-2 
supplemented with Ang-1 or Ang-1 + Ned-19. Quantitative evaluation of tube 
formation as the number of closed polygons formed in 9 fields for each 
experimental condition. Data in bar charts represent percentage of the control 
(mean ± s.e.m. of three independent experiments).  
 
In addition in vivo matrigel assay were performed. Matrigel plugs 
containing either Nar or vehicle or Nar plus Ang-1from injected 
mice were evaluated in hemoglobin content 5 days after inocolum. 
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Bar charts in Figure 9 show that the vascularization of Ang-1 plugs 
did not significantly differ from that in Ang-1 plus Nar plugs. 
Taken together these data indicate that IP3-dependent Ca2+ 
responses and angiogenic process (in vitro and in vivo)  stimulated 
by Ang-1 are not affected by Nar strongly indicating that Nar 
specifically impairs NAADP/TPC2- dependent signalling pathway. 
 
 
 
 
 
 
Figure 9.  Naringenin does not affect angiogenic responses to Ang-1 in vivo. In 
vivo vessel formation was assessed after subcutaneous injection of 5 weeks old 
male/female C57BL/6 mice with Matrigel plugs containing either vehicle or 
Ang-1 (150 ng/ml) or Ang-1 plus 1000 µM Nar. Five days after injection the 
mice were sacrificed and plug vascularization was evaluated as hemoglobin 
content expressed as absorbance (OD)/1 g matrigel plug. Hemoglobin content in 
Ang-1 plugs (n=8) did not significantly differ from that in Ang-1 + Nar plugs 
(n=8) (P>0.2). 
 
 
4.5 Conclusions (1) 
In the present study we demonstrated that Nar can specifically 
inhibit the ability of TPC2 to release Ca2+ from acidic stores in 
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NAADP-mediated responses. Electrophysiological analysis shows 
that hTPC2-current is specifically reduced by Nar. Furthermore, 
we assess the possible effects of Nar on TPC2 in human 
endothelial cells analyzing VEGF-dependent Ca2+ release and 
VEGF-dependent angiogenesis in vitro and in vivo. Both Ca2+-
activated responses of HUVECs to VEGF and in vitro and in vivo 
angiogenesis are inhibited by Nar. In addition, Ang-1-dependent 
angiogenic responses, known to be TPC2-independent, are not 
affected by Nar. Figure 10 describes schematically the specific role 
of Nar in the control of VEGF-induced angiogenesis, based on 
present and previous data. 
 
Figure 10. Schematic representation of specific Ca+2 signalling pathway 
involved in the control of angiogenesis by VEGF and Ang-1. Nar inhibits Ca+2 
mobilization when mediated by TPC2, but not by RyR/InsP3R. AC: acidic 
compartments, ER: endoplasmic reticulum. 
 
 
Besides confirming the inhibitory properties of Nar in VEGF-
induced angiogenesis, the data from the present study shed new 
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light on the mechanisms underlying this process by revealing the 
pivotal role played by TPC2 and provide the first evidence of the 
antiangiogenic properties of Nar in an in vivo murine model. 
Nar is known to exert a wide range of effects induced by a number 
of mechanisms that have yet to be discovered. 
By contrast, a limited number of factors are known to modulate 
TPC2 activity, and our data shed light on a novel, naturally-
occurring molecule that targets this channel which is attracting a 
considerable amount of interest owing to its relevance to important 
pathophysiological processes. The relationship we describe here 
between naringenin and TPC2 is therefore likely to have wider 
implications in systems other than the vascular system, thus 
representing a novel tool for experimental, and possibly even 
clinical, research purposes.  
 
 
 
4.6 Naringenin impairs B16 melanoma cells VEGF-dependent 
Ca2+ responses  
 
In tumor biology Ca2+ signaling pathway represents an important 
aspect. Changes in Ca2+ toolkit lead cancer cells to acquire some 
distinctive hallmarks such as alteration in the expression of 
proteins involved in the mobilization of Ca2+ across the plasma 
membrane and sub-cellular organelles. Many studies have shown 
that Ca2+ is involved in basic processes such as proliferation, 
migration, survival of tumors cells, invasiveness and metastasis 
formation [9-12]. On the basis of this evidence we have recently 
focused our attention on the study of VEGF-dependent Ca2+ 
signaling in cancer cells, starting with murine melanoma. We have 
demonstrated a role for NAADP-evoked Ca2+ signalling in a 
number of melanoma features in vitro and in a murine melanoma 
in vivo model. Using the NAADP inhibitor Ned-19 in B16 
melanoma cell line cultured in vitro or inoculated in C57BL/6 mice 
in vivo we have observed that NAADP controls cellular migratory 
ability, cellular proliferation, tumor vascularization, growth and 
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metastatic dissemination. These data strongly suggest that 
NAADP/TPC2 Ca2+ pathway can be relevant not only for 
neoangiogenesis, but also for a direct control of tumor cells [2]. 
Exploiting Nar ability to block TPC2-mediated responses in 
HUVECs we have investigated  whether Nar could interfere with 
the response of B16 melanoma cells to VEGF. Ca2+ imaging 
experiments were performed in B16 FURA2-AM loaded single 
cells pretreated for 30 min with different concentrations of Nar and 
stimulated with 100 ng/ml VEGF. Histograms in Figure 11a, 
shows that Nar is able to inhibit VEGF-related Ca2+ signalling in a 
dose-dependent manner. Furthermore, to directly assess the 
specific inhibitory effect of Nar treatment on TPC2 in this 
experimental system we have performed Ca2+ imaging experiments 
pretreating cells with Nar and stimulating them with 100 nM 
NAADP-AM. Data in bar charts show that NAADP-mediated Ca2+ 
mobilization is inhibited by Nar, (Figure 11b). In addition, to 
further support our observation we have also performed Ca2+ 
imaging experiments pretreating cells with different concentration 
of Ned-19 (previously demonstrated to inhibit NAADP-dependent 
responses in B16 melanoma cells [2]) and stimulating them with 
100 nM NAADP-AM. As expected, Figure 11c shows that also 
Ned-19 was able to significantly inhibit Ca2+ responses to 
NAADP-AM. Taken as a whole these observations strongly 
suggest a specific inhibitory effect of Nar on TPC2-mediated Ca2+ 
release also in B16 melanoma cells. 
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Figure 11. Naringenin inhibits NAADP-controlled Ca2+ mobilization in B16 
melanoma cells. Ca2+ imaging experiments. Cells pretreated for 30 min with 
different concentration of Nar were stimulated with 100 ng/ml VEGF (a) or 100 
nM NAADP-AM (b). (c) B16 cells pretreated with Ned-19 and stimulated with 
100 nM NAADP-AM. 
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4.7 Naringenin affects the proliferative/migratory behavior of 
B16 melanoma cells  
 
Migration and proliferation are characteristic hallmarks of cancer; 
we have previously demonstrated that NAADP- mediated Ca2+ 
release is required for the migratory ability of B16 cells in their 
own conditioned medium. Indeed, we have shown that Ned-19 
significantly reduces cells migration and focal adhesion kinase 
(FAK) activation, protein known to have an important role in the 
regulation of dynamic changes in actin cytoskeleteon 
reorganization [2]. In order to investigate the possible inhibitory 
effect of Nar on B16 melanoma cells migratory ability, scratch 
assay was performed on confluent monolayers treated or not with 
the inhibitor and cultured for 18 hours in the absence of serum in 
order to minimize the contribution of growth versus migration. 
Figure 12a,b shows that B16 melanoma cells capability to move on 
the wound is inhibited by Nar. In addition western blot analysis of 
P-FAK and P-AKT  levels at the same time and conditions shows 
that Nar significantly impairs FAK and AKT activation allowing to 
attribute, at least in part, the observed behavior to changes in cell 
motility (Figure 12c,d). This point, of potential relevance for the 
control of invasive and metastatic behavior, opens the way to 
further more direct and elaborate approaches, presently ongoing in 
our laboratory. 
We also asked whether in this experiment Nar had interfered with 
the proliferation. To this purpose cell cycle analysis were 
performed in the same experimental conditions (18h, no serum) 
and % G1 and S phase was evaluated in a cytometer. Data in figure 
13 a, b show that Nar treatment significantly abates the percentage 
of cells undergoing S phase and increases the percentage of cells 
undergoing G1 phase. Analyzing these results we cannot exclude 
the contribute of proliferation inhibition on the migration process, 
but this indications suggest that both of them may be affected by 
Nar. We previously demonstrated in B16 melanoma cells the 
important role of NAAD/TPC2 mediated responses on the control 
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of migration and proliferation [2]. Taken together these data 
suggests that Nar can interfere with this control most likely 
through TPC2, a hypothesis which we are presently investigating 
by means of genetic approaches.  
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Figure 12.  Naringenin impairs melanoma migration. (a) Scratch assay to 
investigate B16 melanoma cells ability to move on wound. Wounded monolayer 
were maintained in serum free medium in presence or absence of Nar for 18h. 
Representative images of three independent experiments at the time of manual 
damage t=0 and after 18h. (b) Quantitative evaluation of the percentage of free 
area versus t=0 after 18h. (c,d) Western blot assessment of phosphorylation 
levels of FAK (c) and AKT (d). Cells, treated or not with Nar in a serum free 
medium for 18h, were lysed and western blot analysis was performed.  
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Figure 13. Naringenin interferes with B16 melanoma cell cycle increasing 
G1phase and decreasing S phase. (a,b) Data are representative of three 
independent experiments. Evaluation of (a) % G1 phase (b) % S phase 18h after 
Nar treatment in a serum free medium. 
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4.8 Naringenin interferes with B16 melanoma ability to form 
vascular-like tube network 
The ability of aggressive tumor cells to form vascular channels, a 
phenomenon known as vasculogenic mimicry (VM) has been 
described.  Through this process tumor cells, without implication 
of ECs, form tubes de novo independently of angiogenesis. 
Interestingly, channels are not true blood vessels formed by 
preexisting ones, but mimic capillary function. In addition, a link 
has been highlighted between VM and poor clinical outcomes and 
suggesting that this could explain why some tumors poorly respond 
to angiogenic inhibitors [81, 87]. 
The initial characterization of this tumor plasticity was made in 
melanoma in which cells coexpression of endothelial, tumor 
markers and perfusible vascular-like structures rich in laminin, 
collagens IV and VI and heparin sulfate proteoglycans were 
described [80]. Furthermore, subsequent comparative studies 
between melanoma VM networks versus endothelial-dependent 
angiogenic vasculature reported upregulated expression of key 
angiogenesis-related and stem-cell–associated genes by the 
melanoma cells [81]. 
Interestingly, we have observed that Nar interferes with melanoma 
cells VM. We have seeded B16 melanoma cells on Matrigel and 
culturing them for 18h to allow for the development of capillary-
like tubes. The cells treated in a serum free medium with the 
vehicle alone underwent a rearrangement and formed a 
vasculogenic network within 18h. Otherwise, cells treated with 200 
µM Nar showed a significant inhibition of these structures 
suggesting a possible role for TPC2 in VM, (Figure 14).   
In this study we have introduced the natural flavonoid Nar as a tool 
to directly block TPC2-mediated angiogenic response in HUVECs. 
In addition, VM of B16 melanoma cells is also impaired by Nar; 
although we cannot exclude the possibility that in B16 melanoma 
cells Nar targets pathways different from TPC2, these data suggest 
that this ion channel may have a possible role in endothelial and 
melanoma pathways in the formation of angiogenic and non-
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angiogenic vascular system respectively: a novel promising field 
worth of further insight. 
 
 
 
 
 
 
 
Figure 14. Naringenin inhibits B16 melanoma cells ability to form vascular-like 
structures. Cells were seeded on Matrigel in presence or absence of Nar in a 
serum free medium for 18h. (a) Representative images of one of five 
independent experiments. (b) Quantitative evaluation of tube formation as the 
number of closed polygons formed in 9 fields for each experimental condition. 
Data in bar charts represent fold of treated samples compared with control set as 
1 (mean ± s.e.m. of five independent experiments). 
 
 
 
 
4.9 Concluding remarks 
 
Investigating cancer behavior in the context of its 
microenvironment represents an important aspect in the fight 
against cancer. In particular, angiogenesis has a pivotal role in 
tumor progression and the communication with the surrounding 
environment.  
In literature several studies point out the emerging role of TPCs in 
patophysiological processes [1, 42-48] including cancer [2, 49, 50]. 
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Indeed, we have previously demonstrated TPC2 involvement in 
angiogenesis and NAADP signalling [1, 2].   
In this study we introduce Nar as a novel natural pharmacological 
tool able to interfere with TPC2 activity. In particular, we have 
demonstrated that in endothelial cells Nar specifically inhibits both 
VEGF/NAADP/TPC2-dependent Ca2+ mobilization and 
angiogenesis in vitro and in vivo. On the other side, also data from 
melanoma, although lacking a direct correlation, strongly suggest 
that Nar effects on B16 biological processes may be dependent 
upon TPC2 inhibition. 
Finally, on the basis of this evidence, we can conclude that Nar 
may represent an important natural tool that potentially capable to 
impair NAADP/TPC2 Ca2+ signalling not only in angiogenesis but 
also in melanoma progression pointing out the relevance, for 
clinical application, to develop drugs able to target at the same 
time both processes. 
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5. MATERIALS AND METHODS 
5.1 Arabidopsis thaliana tpc1–2 mutants [88] were grown in soil in 
a growth chamber at 22 °C and 8 h light/16 h dark regime. Well-
expanded leaves from 4 weeks old plants were used for mesophyll 
protoplast preparation as described in refs [89] and [90]. The 
transient transformation was performed as described previously 
[83, 85] using the pSAT-hTPC2-EGFP or pSAT-hTPC1-EGFP 
plasmid as reported therein. 
The transformed cells were maintained in the dark at 23 °C in W5 
ionic solution (in mM: 154 NaCl, 125 CaCl2,KCl 5, MES 2, pH 5.6 
with KOH) plus 50 µg/ml Ampicillin as described in ref. [89]. 
Vacuoles were efficiently released from the protoplasts using the 
following vacuole release solution (in mM): 100 malic acid, 5 
EGTA, 3MgCl2, pH 7.5 using 160 1,3-bis 
(tris(hydroxymethyl)methylamino) propane (BTP), 450 mOsm 
with D-sorbitol. 
 
5.2 Patch-clamp recordings. Patch-clamp experiments on 
vacuoles from fluorescent protoplasts expressing the hTPC2-EGFP 
fusion on the tonoplast were performed in whole-vacuole 
configuration ≥40 h after the transformation. 
The bath solution (cytoplasmic side) contained (in mM): 100 NaCl, 
2 MgCl2, 10 Hepes-Tris, pH 7.5. The pipette solution (vacuolar 
side) was (in mM): 100 NaCl, 2 MgCl2, 10 MES-Tris, pH 5.5. The 
bath solution and the pipette solution were adjusted to 580 mOsm 
and 618 mOsm by the addition of D-sorbitol. Dithiothreitol (DTT; 
2 mM) was added to the vacuole release solution before the patch-
clamp experiments. DTT was prepared as 1 M stock solution the 
day of the experiment and kept on ice until use. Nar was also 
prepared fresh as a stock solution in DMSO. Since the usual 
maximum concentration of Nar used in electrophysiological 
studies (100 µM) induced about 40% inhibition of hTPC2 and even 
less of AtTPC1, we decided to increase [Nar] up to 1000 µM. 
However, some precipitate was present in these conditions possibly 
slightly reducing the nominal Nar concentration. We also verified 
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that the maximum DMSO concentration used in this study (up to 
0.1%) were not effective on channel activity. PI (3,5)P2, purchased 
as dioctanyl ester (diC8) from AG Scientific or Echelon 
Biosciences Inc, was prepared as 1 mM stock solution and stored 
at −20 °C. The other chemicals were purchased from Sigma-
Aldrich and Carl Roth. 
 
5.3Analysis of electrophysiological data. Positive currents 
correspond to cations flowing from the cytoplasmic side to the 
lumen of the vacuole. Data analysis and figure preparation were 
done with Igor Pro software (Wavemetrics) or Photoshop (Adobe 
Inc.). 
 
5.4 Cell culture. HUVECs were obtained from Lonza Sales Ldt, 
cultured in EGM-2 Endothelial Cell Growth Medium-2 
(Endothelial Basal Medium EBM-2 + EGM-2 Bullet Kit, Lonza), 
+ 100 mM Penicillin/Streptomycin (P/S) (Sigma); Cells were used 
at passage 1 to 6.  
B16 F0 melanoma cells ATCC CRL-6322 were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented by 
10% FBS, 2% P/S and 2% L-glutamine (Sigma). 
Both cell lines were maintained at 37 °C in a humidified 5% CO2 
incubator. 
 
Reagents used are: VEGF-A165 (Peprotech), Ang-1 (Peprotech), 
Histamine (Sigma), ATP (Sigma), Ned-19 (Tocris Bioscience) 
Naringenin (Sigma); NAADP-AM was a generous gift of G. C. 
Churchill (Oxford University). 
 
5.5 Calcium imaging. Cells were incubated in EGM-2 or DMEM 
containing 3.5 µM Fura-2-AM (Invitrogen) for 1 h at 37 °C and 
then rinsed with either Hanks’ Balanced Salt Solution (HBSS, 
Sigma) or Ca2+ free Krebs Henseleit Hepes buffer (KHH). Dishes 
were placed into a culture chamber kept at 37 °C controlled 
temperature on the stage of an inverted microfluorimeter (Nikon 
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TE2000E) connected to a cooled CCD camera (512B Cascade, 
Princeton Instruments). Samples were illuminated alternately at 
340 and 380 nm using a random access monochromator (Photon 
Technology International) and emission was detected using a 510 
nm emission filter. Images were acquired (1 ratio image/s) using 
Metafluor software (Universal Imaging Corporation). Calibration 
of the signal was obtained at the end of each experiment by 
maximally increasing intracellular Ca2+-dependent Fura-2 
fluorescence ratio (340/380) with 5 µM ionomycin (ionomycin 
calcium salt from Streptomyces conglobatus, Sigma) followed by 
recording minimal ratio in Ca2+-free medium. [Ca2+]i was 
calculated according to previously described formulas [91]. 
 
5.6 Western Blot. HUVECs were first starved in EBM-2 + 2% 
FBS for 4 h and then incubated with Nar for 30 min or with TSU-
68 (SU6668, Selleckchem), an inhibitor of VEGFR2 tyrosine 
kinase activity, for 1 h before VEGF stimulation for 15 min. The 
primary antibody used was anti-Phospho-VEGF Receptor 2 
(Tyr1175) (Cell Signaling Technology) revealed by Goat Anti-
Rabbit IgG (H+L)-HRP Conjugate (BIO-RAD). To ensure equal 
loading, membranes were reprobed with Monoclonal Anti-α-
Tubulin antibody (Sigma) followed by Goat Anti-Mouse IgG 
(H+L)-HRP Conjugate (BIO-RAD). 
B16 F0 seeded the day before, were rinsed twice with PBS and 
then treated for 18h in serum free medium containing vehicle or 
different concentrations of Nar. The primary antibody used were 
Phospho-FAK (Tyr 925) (Cell Signaling Technology), FAK (Cell 
Signaling Technology), Phospho-AKT (Ser 473) (Cell Signaling 
Technology), AKT (Cell Signaling Technology). Each antibody 
has been revealed by Goat Anti-Rabbit IgG (H+L)-HRP Conjugate 
(BIO-RAD). 
The intensity of western blot bands was quantified by Image Lab 
5.2.1 software (BIO-RAD) from three independent experiments. 
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5.7 In vitro angiogenesis assay. Capillary-like endothelial tube 
formation was evaluated by an in vitro angiogenesis assay. 130 µl 
Matrigel Basement membrane Matrix Growth factor Reduced (BD 
Biosciences) was added to each well of pre-cooled 24-well tissue 
culture plates. Pipette tips and matrigel solution were kept cold 
during the procedure to avoid solidification. The plates were 
incubated for 1 h at 37 °C to allow matrix solution to solidify. 
4 × 104 HUVECs in a final volume of 500 µl EBM-2 + 2% FBS 
were seeded in each matrix-coated well. Cells were pretreated with 
500 µM or 1000 µM Nar or with vehicle alone and stimulated with 
100 ng/ml VEGF for 3–4 hours at 37 °C. Cells stimulated with 100 
ng/ml Ang-1 for 2–3 hours, pretreated with 500 µM Nar or 100 µM 
Ned-19, were seeded in EGM-2. Tube formation was inspected 
under an inverted microscope (Nikon Eclipse TS100) and images 
were acquired by a digital camera (Nikon Ds Fi2, Nis elements F 
4.00.00 software). The closed polygons formed in at least six 
random view microscopic fields per well were counted and values 
averaged. 
 
5.8 In vivo angiogenesis assay. The ability of Nar to modulate 
VEGF-induced neovascularization was tested by matrigel plug 
assay. Matrigel (600 µl, BD Biosciences) supplemented with 
heparin (32 U/ml, Schwarz Pharma S.p.A), VEGF (100 ng/ml, 
Peprotech) or Angiopoietin1 (150 ng/ml, Peprotech), TNF-α (2 
ng/ml, R&D Systems) and ± 1000 µM Nar was injected 
subcutaneously into C57BL/6 mice flanks where it rapidly formed 
a gel. The negative controls contained heparin alone, the positive 
controls heparin plus VEGF and TNF-α. In this assay, cells from 
the surrounding tissues migrate into the matrigel plug and form 
vascular structures connected to the mouse blood vessels. After 5 
days, mice were sacrificed by CO2 asphyxia and the angiogenic 
response was evaluated by macroscopic analysis at necropsy and 
by measurement of the hemoglobin content in the matrigel plug. 
Hemoglobin was mechanically extracted in water and measured 
using the Drabkin method by spectrophotometrical analysis 
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(Sigma) at 540 nm. The values were expressed as optical 
density/100 mg matrigel. 
The animals were housed in the accredited animal facility of the 
Department of Anatomy, Histology, Forensic Medicine and 
Orthopaedics, Unit of Histology and Medical Embryology, 
Sapienza University of Rome, in individual cages, in an 
environmentally controlled room (23 °C, 12 h light-dark cycle) and 
provided with food and water ad libitum. 
All of the procedures were approved by the Italian Ministry for 
Health and conducted according to Italian law. 
 
5.9 Scratch Assay. Confluent B16 F0 cells monolayer were 
scraped along a straight line to create a narrow gap (scratch). Cells 
were rinsed twice with PBS prior the incubation in serum free 
medium in the presence or absence of Nar. To record cell 
migration, images of the wound were acquired at time zero and 
again 18h later. 
 
5.10 Cell cycle analysis. In 18h cell cycle analysis cells were 
serum starved. Propidium iodide (PI) staining: cells were detached 
with trypsin/EDTA and resuspended in phosphate-buffered saline 
(PBS) plus 50 % FBS and then fixed in 70% ethanol for 24h. After 
washing three times with PBS cells were incubated with PI/RNAse 
for 3h at room temperature before FACS analysis using a Coulter 
Epics XL flow cytometer (Beckman Coulter, Fullerton, CA). 
 
5.11 Vascular-like structure formation: Vasculogenic Mimicry. 
2x104 B16 F0 cells per well were seeded onto Matrigel (BD 
Bioscences) in 96-well plates. Before seeding, cells were 
resuspended in fresh serum free medium in presence or absence of 
Nar. The formation of vascular-like tubes was analyzed 18h after 
plating. The vessel like channels were measured as total number of 
closed polygons for each areas in each well. 
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5.12 Statistical analysis. Data are presented as the mean ± s.e.m. 
of results from at least three independent experiments. Student’s t 
test was used for statistical comparison between means where 
applicable. *P < 0.05; **P < 0.01; ***P < 0.001. 
 
5.13 Ethical Standards. All the experiments described fully 
comply with the current laws of Italy 
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6. APPENDIX 
 
 
 
 
Suppl. Figure 1: the human TPC1 channel is expressed in TPC-free 
Arabidopsis vacuoles 
(a) Currents recorded in the absence (left) and in the presence (right) of 90 nM 
PI(3,5)P2 added in the cytosolic bath solution. Currents were elicited by voltages 
ranging to -90 to +80 mV in 10 mV step. Holding and tail voltages were 
respectively of -70 and -50 mV. (b) Steady-state currents obtained as the mean 
values of the last 100 ms recording were plotted against the applied voltages. 
Empty and filled symbols indicated the absence and the presence of 90 nM 
PI(3,5)P2. Data, shown as mean ± s.e.m., were from 7 different vacuoles. 
 
 
Suppl. Figure 2: Naringenin inhibits the Arabidopsis thaliana TPC1 
AtTPC1 channel response to voltage stimulation at V= +80 mV in control, in the 
presence of 300 µM cytosolic Nar and in recovery conditions in vacuoles from 
mesophyll cells of Arabidopsis thaliana plants. Ionic solutions: 200 mM KCl, 2 
mM MgCl2, 2 mM CaCl2, 10 mM MES/Tris, pH 5.5 in the pipette; 100 mM 
KCl, 2 mM MgCl2, 1 mM CaCl2, 1 mM dithiothreitol (DTT), and 10 mM 
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HEPES/Tris, pH 7.5 in the bath; osmolarity adjusted to 600 mOsm by the 
addition of D-sorbitol. Similar experiments were performed from at least 15 
different vacuoles. 
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